Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Delivra Health Brands ( (TSE:DHB) ) has shared an announcement.
Delivra Health Brands Inc. announced it will release its annual financial results for the year ending June 30, 2025, on October 6, 2025. The company will host a conference call on the same day to discuss these results, with the participation of its President and CEO, Gord Davey, and CFO, Jack Tasse. This announcement is significant as it provides stakeholders with insights into the company’s financial performance and strategic positioning in the health and wellness sector.
The most recent analyst rating on (TSE:DHB) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on Delivra Health Brands stock, see the TSE:DHB Stock Forecast page.
Spark’s Take on TSE:DHB Stock
According to Spark, TipRanks’ AI Analyst, TSE:DHB is a Neutral.
Delivra Health Brands is in a recovery phase with improving financial metrics and strategic corporate actions. However, the poor valuation due to negative earnings and lack of dividends weigh heavily on the score. The technical analysis suggests neutral market sentiment, and corporate events are positive, indicating potential for future growth.
To see Spark’s full report on TSE:DHB stock, click here.
More about Delivra Health Brands
Delivra Health Brands Inc. is a leader in the consumer packaged goods sector, specifically focusing on health and wellness. The company offers innovative products such as Dream Water® and LivRelief™, which provide solutions for common issues like chronic pain, anxiety, and sleeplessness, helping customers improve their quality of life.
Average Trading Volume: 13,005
Technical Sentiment Signal: Sell
Current Market Cap: C$6.72M
For detailed information about DHB stock, go to TipRanks’ Stock Analysis page.